Skip to main content
. 2015 Nov 20;182(12):1047–1055. doi: 10.1093/aje/kwv152

Table 4.

Risk of Liver Fibrosis Associated With Alcohol Abuse in the Canadian HIV–Hepatitis C Co-infection Cohort Study, 2003–2014a

Analytical Approach
and Variable
Odds Ratio 95% Confidence Interval
Available-case
 Alcohol abuse 1.55 0.91, 2.38
 Age at baselineb 1.03 0.93, 1.19
 Baseline ln(APRI) 7.29 4.15, 19.61
 Female sex 1.85 0.98, 2.84
 Aboriginal ethnicity 0.64 0.21, 1.07
 HCV RNA-positive at baseline 1.42 0.86, 4.79
 Duration of HCV infectionb 1.00 0.89, 1.25
 HBsAg-positive at baseline 0.99 0.00, 1.91
LOCF
 Alcohol abuse 1.74 0.65, 2.77
 Age at baselineb 0.99 0.84, 1.18
 Baseline ln(APRI) 6.20 1.98, 12.02
 Female sex 1.30 0.90, 2.97
 Aboriginal ethnicity 0.86 0.33, 1.36
 HCV RNA-positive at baseline 1.56 0.73, 2.26
 Duration of HCV infectionb 1.00 0.91, 1.16
 HBsAg-positive at baseline 0.88 0.00, 1.18
Multiple imputation
 Alcohol abuse 1.32 1.11, 1.69
 Age at baselineb 0.99 0.85, 1.09
 Baseline ln(APRI) 4.86 3.02, 8.12
 Female sex 1.26 0.89, 1.57
 Aboriginal ethnicity 1.02 0.63, 1.48
 HCV RNA-positive at baseline 1.12 0.94, 2.09
 Duration of HCV infectionb 1.00 0.97, 1.09
 HBsAg-positive at baseline 1.15 0.68, 2.09

Abbreviations: APRI, aspartate aminotransferase:platelet ratio index; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; LOCF, last observation carried forward.

a The hazard ratio is approximated by the odds ratio obtained from a weighted pooled logistic regression.

b Age and duration of HCV infection were scaled so that the coefficient was associated with a change of 5 years.